Patents by Inventor William Robert Fraser Goundry

William Robert Fraser Goundry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONJUGATES COMPRISING CLEAVABLE LINKERS
    Publication number: 20250073339
    Abstract: The specification relates to conjugates comprising a linker of Formula (IMA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Application
    Filed: August 14, 2024
    Publication date: March 6, 2025
    Inventors: Jonathan David BEADLE, Albano GALAN COCA, Mattia COCCO, William Robert Fraser GOUNDRY
  • CONJUGATES COMPRISING CLEAVABLE LINKERS
    Publication number: 20250057969
    Abstract: The specification relates to conjugates comprising a linker of Formula (IA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Application
    Filed: August 14, 2024
    Publication date: February 20, 2025
    Inventors: Jonathan David BEADLE, Albano GALAN COCA, Mattia COCCO, William Robert Fraser GOUNDRY
  • Conjugates comprising cleavable linkers
    Patent number: 12178876
    Abstract: The specification relates to conjugates comprising a linker of Formula (ICA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Grant
    Filed: April 9, 2024
    Date of Patent: December 31, 2024
    Assignee: AstraZeneca, AB
    Inventors: Akbar Husain Khan, Andreas Lothar Severino Maderna, Maximillian Taro William Lee, Nicole Danielle Bartolo, William Robert Fraser Goundry
  • CONJUGATES COMPRISING CLEAVABLE LINKERS
    Publication number: 20240366781
    Abstract: The specification relates to conjugates comprising a linker of Formula (IA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Application
    Filed: April 9, 2024
    Publication date: November 7, 2024
    Inventors: Akbar Husain KHAN, Andreas Lothar Severino MADERNA, Maximillian Taro William LEE, Mattia COCCO, Boliang DENG, Jonathan David BEADLE, Albano GALAN COCA, Alla PRYYMA, Nicole Danielle BARTOLO, Luke MASTERSON, William Robert Fraser GOUNDRY
  • CONJUGATES COMPRISING CLEAVABLE LINKERS
    Publication number: 20240366768
    Abstract: The specification relates to conjugates comprising a linker of Formula (ICA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Application
    Filed: April 9, 2024
    Publication date: November 7, 2024
    Inventors: Akbar Husain KHAN, Andreas Lothar Severino MADERNA, Maximillian Taro William LEE, Nicole Danielle BARTOLO, William Robert Fraser GOUNDRY
  • Process for the preparation of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-([1-(N-methylcarbamoymethyl)piperidin-4-yl]oxy)quinazoline
    Patent number: 8450482
    Abstract: Processes for the preparation of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline, salts thereof, and the intermediates used in the process are described.
    Type: Grant
    Filed: April 22, 2010
    Date of Patent: May 28, 2013
    Assignee: Astrazeneca AB
    Inventors: Kay Alison Boardman, Oliver Robert Cunningham, William Robert Fraser Goundry, David Dermot Patrick Laffan
  • PROCESS 738
    Publication number: 20120108814
    Abstract: Processes for the preparation of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline, salts thereof, and the intermediates used in the process are described.
    Type: Application
    Filed: April 22, 2010
    Publication date: May 3, 2012
    Applicant: AstraZeneca AB
    Inventors: Kay Alison Boardman, Oliver Robert Cunningham, William Robert Fraser Goundry, David Dermot Patrick Laffan